2 Methodology The research protocol for this study was registered with the International Prospective Register of Systematic Reviews (PROSPERO) with registration number CRD420251157476
Although not commonly reported, ICI therapy-related pyrexia was associated with a longer PFS in one study (6.4 versus 2.1 months
Participants taking semaglutide showed significant reductions in major cardiovascular events, including heart attack and stroke, compared to placebo
Primary Handling Editor: Christoph Schmitt, in collaboration with the Nature Metabolism team
83 There are some inconsistencies in the data which indicate that caution should be shown, despite the huge interest in ghrelin and its putative role in stimulating eating
Without ongoing behavioral support, the post says, patients revert to pre-treatment eating patterns